Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 544,302 $ 149,971
General and administrative 1,142,544 2,177,569
Total operating expenses 1,686,846 2,327,540
Operating loss (1,686,846) (2,327,540)
Other expense, net (16,708)
Loss before income taxes (1,703,554) (2,327,540)
Income taxes
Loss from operations (1,703,554) (2,327,540)
Net loss $ (1,703,554) $ (2,327,540)
Loss per common share - basic and diluted (in dollars per share) $ (0.45) $ (0.98)
Weighted average shares outstanding, basic and diluted (in shares) 3,786,913 2,382,757